An Umbrella Study to Explore Precision Treatment of Colorectal Cancer Based on Molecular Typing

ABSTRACT: Interventions: Cohort 1:Trastuzumab + Camrelizumab + Irinotecan;Cohort 2:Cetuximab + Pyrotinib + Irinotecan;Cohort 3:Cetuximab + MEK Inhibitor + Irinotecan;Cohort 4:PARP Inhibitor + Irinotecan Primary outcome(s): Objective Response Rate Study Design: Factorial

DISEASE(S): Colorectal Cancer

PROVIDER: 2688563 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR